CXCL17 and breast cancer: Given the prominent role of CD11b+Gr-1+ MDSCs in breast cancer metastasizing to the lungs, we next examined whether depletion of CD11b+Gr-1+ MDSCs could decrease lung metastasis of breast cancer induced by CXCL17.